|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/451 | |
| A61K 31/485 | |||
| A61K 39/395 | |||
| A61K 45/06 |
| (11) | Number of the document | 1861096 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06748298.4 |
| Date of filing the European patent application | 2006-03-07 | |
| (97) | Date of publication of the European application | 2007-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/007892 |
| Date | 2006-03-07 |
| (87) | Number | WO 2006/096626 |
| Date | 2006-09-14 |
| (30) | Number | Date | Country code |
| 659193 P | 2005-03-07 | US | |
| 725703 P | 2005-10-12 | US | |
| 731009 P | 2005-10-28 | US | |
| 760851 P | 2006-01-20 | US |
| (72) |
MOSS, Jonathan, US
LINGEN, Mark, US
SINGLETON, Patrick A., US
GARCIA, Joe G.N., US
|
| (73) |
The University of Chicago,
5801 South Ellis Avenue, Chicago, IL 60637,
US
|
| (54) | USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION |
| USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION |